NewsRoom Articles - Page 36 of 154 - PsychedelicNewsWire (PNW)

WednesdayMar 15, 2023 11:31 am

Senators File Revised Bill Seeking to Reschedule Breakthrough Psychedelic Therapies

A group of bicameral and bipartisan lawmakers has filed a revised bill that would reschedule psychedelics as breakthrough therapies and promote psychedelic research and drug development. Filed by Senators Rand Paul and Cory Booker alongside Representatives Nance Mae and Madeleine Dean, the Breakthrough Therapies Act seeks to streamline the federal process of rescheduling “breakthrough therapies” such as MDMA and psilocybin that have exhibited significant medical potential. Thanks to a surge in psychedelic research in recent years, scientists have discovered that psychedelics have the potential to treat mental health disorders such as major depressive syndrome, anxiety and post-traumatic stress disorder. The…

TuesdayMar 14, 2023 12:59 pm

How Psychedelics Could Benefit Mental Health of Women

Over the past couple of years, loosening psychedelic policies worldwide have led to a significant surge in psychedelic research. The result threatens to revolutionalize the psychiatric industry completely. Research and clinical studies have revealed that psychedelics such as psilocybin, ketamine and MDMA have the potential to treat a variety of mental health disorders at relatively little doses and with minimal side effects. The U.S. Food and Drug Administration has already approved the use of ketamine-assisted therapies to alleviate treatment-resistant depression in adults, and other psychedelics have exhibited significant potential in clinical studies. With proper investment and support from lawmakers, the…

MondayMar 13, 2023 1:04 pm

Now Could Be Good Time for Investors to Add Psychedelic Stocks to Portfolios

Psychedelics have been enjoying increased media attention in recent years due to their therapeutic potential. Research and clinical studies on the applications of hallucinogenic drugs has revealed that they are capable of treating the symptoms of mental health conditions such as major depressive disorder, anxiety and post-traumatic stress disorder. Amid this influx of scientific literature, lawmakers in several state and local governments have been working on measures to legalize psychedelic use for medical purposes. Like America’s state-legal marijuana sector, psychedelics are going through a renaissance that has allowed the substances to slowly emerge from prohibition as a potential treatment for…

MondayMar 13, 2023 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression

A recent medical study found that psychedelic drugs showed promise as a treatment alternative for hard-to-treat depression Psychedelics were found to activate a greater number of serotonin 2A receptors then traditional antidepressant drugs, largely because of their ability to penetrated through cells’ fatty outer membranes The study reinforces the potential use of psychedelic drugs, and psilocybin in particular, as a treatment methodology for a variety of mental health related conditions Silo Pharma, a developmental stage biopharmaceutical company has long focused around merging traditional therapeutics with psychedelic research In a study carried out between 2013 to 2016, researchers found that 8.1%…

FridayMar 10, 2023 11:46 am

Is Now the Time for Insurers, Employers to Cover Psychedelic Treatments?

A recent surge in psychedelic research has revealed that psychedelics appear capable of treating mental health conditions such as treatment-resistant depression and post-traumatic stress disorder. Although much of this research is still in its infancy, it is definitive enough that lawmakers in several states, cities and local governments are considering legalizing psychedelic treatments. Oregon passed a measure allowing psychedelics for mental health treatments last year, and several cities, including Arcata, Ann Arbor, Denver and Detroit have passed legislation to decriminalize psychedelics. As more states and cities consider decriminalizing psychedelics, insurers and employers may have to start covering psychedelic treatments. Dr.…

ThursdayMar 09, 2023 1:22 pm

Ferndale Becomes Fourth Michigan City to Decriminalize Entheogens

The city of Ferndale has joined a small but growing number of cities in Michigan that have decriminalized entheogenic plants such as DMT, psilocybin mushrooms and ayahuasca. The Ferndale City Council announced last week that a motion to decriminalize entheogens had received unanimous approval. While the resolution doesn’t legalize entheogens outright, it will make the prosecution of entheogen-related offenses a low priority for law enforcement. The resolution comes amid a surge in psychedelic research which revealed that hallucinogenics such as ayahuasca and magic mushrooms have potential mental health benefits. According to the resolution, clinical and scientific studies coupled with traditional…

WednesdayMar 08, 2023 2:03 pm

Risks of Buying Psilocybin Mushrooms from Online Suppliers

An analysis of data collected by the National Survey on Drug Use and Health from 2015–2018 found that an estimated 9.68% of Americans reported lifetime psilocybin use despite the psychedelic’s controlled status at the federal level. However, now that recent research has revealed that psychedelics such as psilocybin, ketamine and mescaline have mental health benefits, their popularity has skyrocketed. Investors are pouring millions of dollars into research to develop psychedelic-assisted therapies, while lawmakers across the country are considering legislation to allow psychedelic use for medical purposes. In the meantime, a market for psilocybin has emerged online that grants Americans across…

TuesdayMar 07, 2023 1:46 pm

VA Starts Considering Psychedelics as PTSD Treatments

After decades of federal prohibition prevented the research and medical use of psychedelic drugs, the U.S. Department of Veteran Affairs is now considering opening the door to psychedelic treatments for veterans. Research in the 1960s first revealed that psychedelics had therapeutic properties, but prohibition made it impossible for researchers to study hallucinogenic drugs. A recent surge in psychedelic research has shown that psychedelics such as ketamine, ayahuasca and psilocybin, can treat mental disorders, including treatment-resistant depression, post-traumatic stress disorder and anxiety. This makes these substances perfect for military veterans who have an elevated risk of developing conditions such as PTSD…

MondayMar 06, 2023 2:01 pm

Genetic Testing May Predict Individuals’ Reaction to Psychedelics

Recent advancements in psychedelic research have revealed that hallucinogenic drugs, such as psilocybin and LSD, may have potent therapeutic properties. Studies into the effects of psychedelics on mental health have found that they can treat the symptoms of various mental disorders with minimal side effects. When combined with psychotherapy, psychedelics have been found to deliver profound and long-term benefits to users at minimal doses. Lawmakers in several states are currently working on legislation to expand psychedelic research and allow the general public to access psychedelic-assisted psychotherapy. However, before psychedelic therapies can hit the market in masses, researchers will have to…

FridayMar 03, 2023 11:51 am

Research Finds Mystical Psychedelic Experiences May Boost Mental Health

Psychedelics are poised to revolutionize the psychiatric industry over the next couple of decades. In the midst of a global mental health crisis that has affected more than a billion people around the world, researchers have been working to develop psychedelic-assisted therapies to treat a myriad of mental health disorders. Research has revealed that psychedelics can treat the symptoms of conditions such as post-traumatic stress disorder, treatment-resistant depression, anxiety and even eating disorders. Furthermore, prior studies have shown that psychedelics can deliver long-term benefits at relatively small doses and with hardly any negative side effects. A recent study has now…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000